Infected Blood Inquiry Reopens Amid Compensation Delays

Victims of the UK's infected blood scandal have spoken out as a public inquiry reopens to scrutinize the government's response to compensation for those affected by contaminated blood products issued between the 1970s and early 1990s. Many victims and campaigners, including those who lost family members or suffered lifelong health consequences, expressed frustration and distress over delays and what they view as inadequate implementation of the compensation scheme. Inquiry chair Sir Brian Langstaff cited ongoing reports of 'distrust, distress and frustration' regarding the pace and fairness of payments, with some fearing they will not live to see justice. Although the government has paid out tens of millions so far and set aside £11.8 billion for the scheme, critics say the process is 'too slow' and lacks transparency, leaving many still waiting for answers and support. The reopened hearings aim to address these concerns, focusing on the timeliness and adequacy of the compensation response and hoping to prompt urgent action to remedy shortcomings. Campaigners continue to emphasize that comprehensive and timely justice for all victims is essential.